Walgreens Boots Alliance, Inc.
—- Market cap
- —
- Debt
- +$11.09B
- Cash
- −$1.32B
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: WBA stock price vs TGT: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at TGT's multiple
Needs TGT P/S.
Implied fair value · at WBA's multiple
Needs Revenue / share, WBA P/S.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Higher is better
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
WALGREENS BOOTS ALLIANCE, INC. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
TARGET CORP · implied price per share
Reporting currency could not be verified.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
TGT · not enough data.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe WBA can convert its 6.2% revenue growth into positive operating margin and ROIC, then the stock could become more attractive, but based on the current data TGT is the stronger relative value because it is profitable, higher quality, and materially better on return metrics.
On the provided P/S framework, TGT-implied value is $110.82, with the valuation range tightly anchored at $110.70-$110.70, suggesting essentially no dispersion in the estimate. The relative setup is not supported by fundamentals because WBA is loss-making while TGT remains profitable and generates positive margins.
Supporting Metrics